Fig. 6

The mRNA expression levels of Thy-1 (a), MMP-9 (b) and β-actin. Total mRNA was extracted and isolated from the sham procedure retinas (Group 1) or the ischemic retinas preadministered with vehicle (Group 2), or low (2.8 g/Kg/day; Group 3)/high dose (4.2 g/kg/day) of CJDHW (Group 4). We evaluated the effect of each defined compound on the mRNA concentrations of Thy-1 or MMP-9 divided by the mRNA levels of β-actin. **represents significance (P < 0.01; Group 1 vs. 2). ^† or ^††represents significance for Thy-1 (P < 0.05; Group 2 vs. 4) or MMP-9 (P < 0.01; Group 2 vs. 4), respectively. The findings are presented as the mean ± SD (Thy-1, n = 5; MMP-9, n = 3–4)